Prognosis of patients with resected non-small cell lung cancer: Impact of clinical and pathologic variables
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 52 (2) , 207-212
- https://doi.org/10.1016/j.lungcan.2006.01.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literatureLung Cancer, 2005
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Oncology, 2004
- Postoperative chemotherapy for non–small cell lung cancer: A systematic review and meta-analysisThe Journal of Thoracic and Cardiovascular Surgery, 2004
- A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the LungNew England Journal of Medicine, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Revisions in the International System for Staging Lung CancerChest, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995